Ignite Creation Date:
2025-12-25 @ 12:36 AM
Ignite Modification Date:
2026-01-02 @ 8:49 AM
Study NCT ID:
NCT05213767
Status:
UNKNOWN
Last Update Posted:
2022-01-28
First Post:
2022-01-26
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Clinical Study to Evaluate the Tolerability and Pharmacokinetics of TQB2916 Injection in Patients With Advanced Malignant Tumors
Sponsor:
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-02
Start Date Type:
ESTIMATED
Primary Completion Date:
2023-05
Primary Completion Date Type:
ESTIMATED
Completion Date:
2023-07
Completion Date Type:
ESTIMATED
First Submit Date:
2022-01-26
First Submit QC Date:
None
Study First Post Date:
2022-01-28
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-01-26
Last Update Post Date:
2022-01-28
Last Update Post Date Type:
ACTUAL